Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO
|
3 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.700 | 0 | ||||||||
Arteriosclerosis
|
267 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Atherosclerosis
|
281 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Coronary heart disease
|
1178 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.030 | 1.000 | 3 | 2005 | 2013 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 0.500 | 2 | 2006 | 2007 | |||||
Metabolic Syndrome X
|
591 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.070 | 1.000 | 7 | 2007 | 2016 | |||||
Obesity
|
1111 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.060 | 1.000 | 6 | 2007 | 2015 | |||||
Coronary Artery Disease
|
1577 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.050 | 0.800 | 5 | 2007 | 2018 | |||||
Hypertriglyceridemia
|
169 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.050 | 1.000 | 5 | 2007 | 2012 | |||||
Cardiovascular Diseases
|
711 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 1.000 | 2 | 2007 | 2013 | |||||
Coronary Arteriosclerosis
|
440 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Diabetes Mellitus
|
824 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.030 | 1.000 | 3 | 2008 | 2014 | |||||
Ischemic stroke
|
704 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.030 | 1.000 | 3 | 2008 | 2017 | |||||
Cerebrovascular accident
|
591 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 1.000 | 2 | 2008 | 2010 | |||||
Diabetes
|
710 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||
Dyslipidemias
|
184 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.020 | 1.000 | 2 | 2008 | 2015 | |||||
Diabetic dyslipidaemia
|
11 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Hyperlipoproteinemia Type I
|
64 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Triglycerides measurement
|
1418 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.800 | 1.000 | 4 | 2009 | 2019 | |||||
Hypertensive disease
|
1085 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||
Avascular Necrosis of Femur Head
|
20 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Atherogenic dyslipidaemia
|
9 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Nuchal bleb, familial
|
9 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Myocardial Infarction
|
680 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Serum total cholesterol measurement
|
1243 | 0.708 | 0.400 | 11 | 116791691 | missense variant | G/A;C | snv | 3.0E-05; 6.8E-02 | 0.700 | 1.000 | 3 | 2018 | 2019 |